Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00418002
Status:
COMPLETED
Last Update Posted:
2007-06-22
First Post:
2007-01-03
Brief Title:
Safety and Tolerability of AQW051 in Elderly Healthy Volunteers
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Randomized Double-Blind Ascending Dose Placebo-Controlled Single Dose Study in Non-Smoking Healthy Elderly Subjects Interleaved With a 2-Week Multiple Once Daily Dose Study to Explore Safety Tolerability Pharmacokinetics and Cognitive Effects After Oral Administration of AQW051
Status:
COMPLETED
Status Verified Date:
2007-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess safety and tolerability of AQW051 administered in single and multiple doses to elderly healthy volunteers In addition pharmacokinetic effects will be assessed and the possible effects on cognition
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None